Vascular biology: a route to novel cardiovascular drugs

Tommy Abrahamsson, Adriano Henney, German Camejo and Mikael Dohlsten
Additional contact information
Tommy Abrahamsson: AstraZeneca R & D, Research Area Cardiovascular & Gastrointestinal
Adriano Henney: AstraZeneca R & D, Research Area Cardiovascular & Gastrointestinal
German Camejo: AstraZeneca R & D, Research Area Cardiovascular & Gastrointestinal
Mikael Dohlsten: AstraZeneca R & D, Research Area Cardiovascular & Gastrointestinal

Nature, 2000, vol. 407, issue 6801, 270-270

Date: 2000
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35025242 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:407:y:2000:i:6801:d:10.1038_35025242

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35025242

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().